Le Lézard
Classified in: Health
Subjects: CCA, TDS, FVT

Universal Health Services, Inc. To Present At The 36th Annual JP Morgan Healthcare Conference


KING OF PRUSSIA, Pa., Jan. 4, 2018 /PRNewswire/ -- Universal Health Services, Inc. (NYSE: UHS) announced today that Steve Filton, Executive Vice President and Chief Financial Officer will present at the 36th Annual JP Morgan Healthcare Conference in San Francisco, CA, on Wednesday, January 10, 2018 at 4:30 p.m. (PST).  A live audio webcast of the presentation will be available on the Company's website (www.uhsinc.com).  For those unable to listen to the live webcast, a replay will be available on the Company's website for 90 days following the conferences.

Universal Health Services (NYSE: UHS) is one of the largest and most respected hospital management companies in the nation. For nearly 40 years, UHS and its affiliates have focused on meeting patients' healthcare needs across hundreds of local communities. Today, UHS subsidiaries own and/or operate 357 inpatient and outpatient facilities including acute care hospitals, behavioral health facilities, ambulatory centers, freestanding emergency departments, and urgent care centers in 37 states, Washington, D.C., the United Kingdom, Puerto Rico, and the U.S. Virgin Islands. For additional information on the Company, visit our web site: http://www.uhsinc.com.

SOURCE Universal Health Services, Inc.


These press releases may also interest you

at 07:15
IPA (IMMUNOPRECISE ANTIBODIES LTD.) (the "Company" or "IPA") , InterSystems, a creative data technology provider dedicated to helping customers solve their most critical scalability, interoperability, and speed challenges, together with ImmunoPrecise...

at 07:10
Can-Fite BioPharma Ltd. , a biotechnology company advancing a pipeline of proprietary small molecule drugs that address oncological and inflammatory diseases, today announced financial results and clinical updates for the twelve months ended...

at 07:10
Kelonia Therapeutics, a biotech company revolutionizing in vivo gene delivery, today announced the appointments of global leaders in cell therapy and drug development, Kristen Hege, M.D., and Mathai Mammen, M.D., Ph.D., to its board of directors....

at 07:05
Aldeyra Therapeutics, Inc. (Aldeyra), a biotechnology company devoted to discovering and developing innovative therapies designed to treat immune-mediated and metabolic diseases, today announced the clinical development plan intended to enable...

at 07:05
Mythic Therapeutics, a clinical-stage biotechnology company committed to the development of next-generation antibody-drug conjugate (ADC) therapies for the treatment of a wide range of cancers, announced that George Eliades, Ph.D., has joined the...

at 07:05
Seres Therapeutics, Inc. ("Seres" or the "Company"), a leading microbiome therapeutics company, today announced that on March 25, 2024, the Compensation and Talent Committee of Seres' board of directors granted inducement equity grants covering an...



News published on and distributed by: